In this issue:
Duloxetine treatment for knee OA
6-week treatment with 10 mg prednisolone for hand OA
Comparative efficacy and safety of treatments for secondary Raynaud’s phenomenon
Upadacitinib vs placebo or adalimumab in patients with RA and an inadequate response to MTX
Efficacy, tolerability, and safety of fasinumab in OA pain
Risk of malignancies and infections in patients with RA initiating abatacept vs other biologics
Safety and immune response of a live-attenuated herpes zoster vaccine in patients with SLE
Non-severe EGPA: Long-term outcomes after remission-induction trial
CV risk of allopurinol vs febuxostat in patients with gout
Impact of exercise therapy on biomarkers in patients with knee OA
Please login below to download this issue (PDF)